Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University